Cyclerion Therapeutics Inc (NASDAQ:CYCN) has a beta value of 1.80 and has seen 24.6 million shares traded in the recent trading session. The company, currently valued at $4.89M, closed the recent trade at $1.80 per share which meant it gained $0.44 on the day or 32.43% during that session. The CYCN stock price is -191.67% off its 52-week high price of $5.25 and 29.44% above the 52-week low of $1.27. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.38 million shares traded. The 3-month trading volume is 226.92K shares.
Cyclerion Therapeutics Inc (NASDAQ:CYCN) trade information
Sporting 32.43% in the green today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the CYCN stock price touched $1.80 or saw a rise of 16.28%. Year-to-date, Cyclerion Therapeutics Inc shares have moved -46.24%, while the 5-day performance has seen it change -13.83%. Over the past 30 days, the shares of Cyclerion Therapeutics Inc (NASDAQ:CYCN) have changed -40.76%. Short interest in the company has seen 14439.0 shares shorted with days to cover at 0.78.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cyclerion Therapeutics Inc (CYCN) estimates and forecasts
The company’s shares have lost -30.73% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 36.06% over the past 5 years.
CYCN Dividends
Cyclerion Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cyclerion Therapeutics Inc (NASDAQ:CYCN)’s Major holders
Insiders own 21.90% of the company shares, while shares held by institutions stand at 40.41% with a share float percentage of 51.74%. Investors are also buoyed by the number of investors in a company, with Cyclerion Therapeutics Inc having a total of 17.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Select Portfolios – Biotechnology and Vanguard Extended Market Index Fund. As of Sep 30, 2024, the former fund manager holds about 1.41% shares in the company for having 38.31 shares of worth $71350.0 while later fund manager owns 23.49 shares of worth $43743.0 as of Jun 30, 2024, which makes it owner of about 0.87% of company’s outstanding stock.
